Nureca

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0DSF01015
  • NSEID: NURECA
  • BSEID: 543264
INR
305.05
-0.45 (-0.15%)
BSENSE

Dec 05

BSE+NSE Vol: 25.72 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Nureca Ltd stock-summary
stock-summary
Nureca Ltd
Micro Cap
Healthcare Services
Nureca Limited was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. The Company is engaged in the business of home healthcare and wellness products. The Company is engaged in the business of home healthcare and wellness products.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 10.00 Cr
Number of Shares
1 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
23-Feb-2021
1
10.00
2500175
10
Public Issue
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.07%)

Promoter with highest holding

Saurabh Goyal (32.17%)

Highest Public shareholder

None

Individual Investors Holdings

32.15%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Saurabh Goyal
Chairman & Managing Director
1.8 cr
Vijay Kumar Sharma
Independent Director
4.0 lacs
Charu Singh
Independent Director
53.0 k
Ruchita Agarwal
Independent Director
42.0 k
Vikram Chaudhary
Independent Director
30.0 k
Chetna Anand
Company Sec. & Compli. Officer
0
Aryan Goyal
Whole Time Director & CEO
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase of Stock-in-Trade
86.489
0%
 
100
Purchase of Stock-in-Trade
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
38 Cr
(Quarterly Results - Sep 2025)
Net Profit:
4 Cr
stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 305 Cr (Micro Cap)

stock-summary
P/E

74.00

stock-summary
Industry P/E

86

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

2.07%

stock-summary
Price to Book

1.54